# Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

> **NCT00301509** · PHASE2,PHASE3 · COMPLETED · sponsor: **Casa Sollievo della Sofferenza IRCCS**

## Conditions studied

- Liver Cirrhosis, Experimental

## Interventions

- **DRUG:** peginterferon and ribavirin

## Key facts

- **NCT ID:** NCT00301509
- **Lead sponsor:** Casa Sollievo della Sofferenza IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** — (—)
- **Last updated:** 2006-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301509, "Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00301509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*